3.95
-0.07(-1.74%)
Currency In USD
| Previous Close | 4.02 |
| Open | 3.96 |
| Day High | 4.12 |
| Day Low | 3.89 |
| 52-Week High | 7.63 |
| 52-Week Low | 2.37 |
| Volume | 566,697 |
| Average Volume | 970,389 |
| Market Cap | 502.53M |
| PE | -79 |
| EPS | -0.05 |
| Moving Average 50 Days | 3.92 |
| Moving Average 200 Days | 4.08 |
| Change | -0.07 |
If you invested $1000 in Cytek Biosciences, Inc. (CTKB) since IPO date, it would be worth $210.55 as of October 19, 2025 at a share price of $3.95. Whereas If you bought $1000 worth of Cytek Biosciences, Inc. (CTKB) shares 3 years ago, it would be worth $271.29 as of October 19, 2025 at a share price of $3.95.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
GlobeNewswire Inc.
Oct 15, 2025 9:00 PM GMT
Cytek European Facility Cytek’s new facility in Amsterdam, The Netherlands, expands the company’s capacity to meet the growing demand for comprehensive cell analysis solutions. FREMONT, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- In a move that s
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
GlobeNewswire Inc.
Sep 10, 2025 9:00 PM GMT
Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and DiscoveryFREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow c
Cytek Biosciences to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire Inc.
Jul 23, 2025 8:05 PM GMT
FREMONT, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the second quarter 2025 after market close on Wednesday, August 6, 2025